Statistical methodology of phase III cancer clinical trials: advances and future perspectives. by Sylvester, R, Van Glabbeke, M, Collette, L, Suciu, S, Baron, B, Legrand, C, Gorlia, T, Collins, G, Coens, C, Declerck, L, Therasse, P

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study by Matthias Preusser, Tomáš Kazda, Emilie Le Rhun, Felix Sahm, Marion Smits, Jens Gempt, Johan AF Koekkoek, Angelo F Monti, Marcell Csanadi, János György Pitter, Helen Bulbek, Beatrice Fournier, Caroline Quoilin, Thierry Gorlia, Michael Weller, Giuseppe Minniti, on behalf of the European Organisation for Research, Treatment of Cancer (EORTC) Brain Tumor Group

Get full text